Assertio Holdings | DEPO - Net Income

Stock Price
12.38
Daily Change
0.17 1.35%
Monthly
21.20%
Yearly
-1.97%
Q1 Forecast
0.88

Assertio Holdings reported $-2.92M in Net Income for its fiscal quarter ending in September of 2024.





Net Income Change Date
ANI Pharmaceuticals USD 26.27M 18.13M Sep/2025
Assertio Holdings USD -2.92M 753K Sep/2024
Aurora Cannabis CAD -51.47M 36.26M Sep/2025
Cara Therapeutics USD -4.91M 2.77M Mar/2025
Daiichi Sankyo JPY 86.63B 41.32B Dec/2025
Ironwood Pharmaceuticals USD 3.19M 457K Dec/2024
J&J USD 5.12B 36M Dec/2025
Knight Therapeutics CAD 85K 2.03M Sep/2024
Merck USD 2.96B 2.82B Dec/2025
Nektar Therapeutics USD -37.06M 15.31M Sep/2024
Omeros USD -32.23M 23.81M Sep/2024
Pfizer USD -1.65B 5.19B Dec/2025
Teva Pharmaceutical Industries USD 480M 47M Dec/2025